CDSCO License for Cervical cytology scraper, single-use
Medical Device Information
Intended Use
A hand-held, manual, blunt surgical instrument designed to scrape and retrieve cytological material from the surface of the cervix (neck of the uterus) or vaginal area for pathological examination and diagnosis, often for the detection of cervical cancer. This is a single- use device.

Comprehensive Guide to CDSCO Licensing for Cervical Cytology Scraper, Single-Use (Class B Medical Device)
As a trusted regulatory consultancy with over 25 years of experience assisting 500+ medical device manufacturers and importers, we understand the complexities of navigating CDSCO licensing in India. This detailed guide focuses on the Cervical Cytology Scraper, a single-use, Class B medical device used extensively in oncology for cervical cancer screening. Our goal is to provide you with practical, actionable insights to facilitate a smooth and timely regulatory approval process.
Understanding the Cervical Cytology Scraper and Its Regulatory Importance
A cervical cytology scraper is a handheld, manual blunt instrument designed for collecting cytological samples from the cervix or vaginal areas. Given its role in early detection of cervical cancer, ensuring compliance with Indian regulatory standards is paramount to guarantee patient safety and product efficacy. The device falls under risk Class B according to CDSCO’s classification, which mandates a specific licensing process under the MD5 license framework.
CDSCO Regulatory Framework for Cervical Cytology Scraper
The Central Drugs Standard Control Organisation (CDSCO) governs medical device regulation in India. For Class B devices like the cervical cytology scraper, the State Licensing Authority grants the manufacturing license (MD5) based on a comprehensive review process including testing, document verification, and audit.
Manufacturers and importers must comply with the Medical Device Rules 2017 and relevant notifications, such as your device’s notification file no. 29/Misc./03/2020-DC (153) — Part 1 dated 11.10.2022. Utilizing the CDSCO MD Online Portal is mandatory for submitting and tracking your application.
Risk Classification and License Requirements for Class B Devices
Your cervical cytology scraper is Class B due to its moderate risk profile involving contact with mucous membranes and potential exposure to patient biological materials.
- License Required: MD5 Manufacturing License
- Applicable Authority: State Licensing Authority
- Application Form: MD3 for license application; MD13 for initial test license
For more on device classification, refer to our Medical Device Classification guide.
Manufacturing License Process (MD5) for Cervical Cytology Scraper
The MD5 license process is structured to ensure devices meet quality, safety, and performance standards before entering the Indian market. Here’s a stepwise breakdown:
- Test License Application (Form MD13): This initial step takes approximately 1.5 to 2 months and allows sample testing.
- Product Testing: Conducted at government-approved laboratories listed on the CDSCO Testing Laboratories. Testing focuses on biocompatibility, sterility, and performance.
- Document Preparation: Assemble all technical and compliance documents.
- Application Submission (Form MD3): Submit the manufacturing license application via the online portal.
- Audit by Notified Body: A notified body, selected from the CDSCO Notified Bodies List, will audit your manufacturing facility and quality systems.
- Query Resolution: Address any queries raised by the licensing authority or notified body promptly.
- License Grant (Form MD5): Upon satisfactory review, the manufacturing license is issued.
Manufacturing License Documents Required for Cervical Cytology Scraper
Preparing a comprehensive dossier is critical. For Class B devices, the following documents are mandatory:
- Company Constitution: Certificate of incorporation, partnership deed, or equivalent
- Proof of Ownership or Rent Agreement: Valid proof for premises
- Technical Staff Qualification Documents: Details of qualified personnel responsible for production and quality control
- Fire NOC & Pollution Control NOC: Compliance with local safety norms
- Device Master File (DMF): Detailed device design and manufacturing information (Device Master File Guide)
- Plant Master File (PMF): Manufacturing processes and quality assurance details (Plant Master File Guide)
- Essential Principles Checklist: Compliance with Indian medical device regulations
- Risk Management File: Hazard analysis and mitigation strategies (Risk Management Guide)
- Test Reports: From government-approved labs verifying safety and performance
- Labeling and Instructions for Use (IFU): As per CDSCO guidelines
- Quality Management System Documents: ISO 13485:2016 certification and SOPs
Import License Process (MD15) for Cervical Cytology Scraper
If you plan to import this device into India, the process requires an MD15 import license granted by the Central Licensing Authority.
- Application Form: MD14
- Timeline: Approximately 5 to 6 months
- Key Documents: Manufacturing license from country of origin, free sale certificate, ISO 13485 certification, CE certificate, Device and Plant Master Files, wholesale license, and company constitution.
For a detailed step-by-step, consult our Import License Guide.
Timeline and Processing Duration for MD5 License
The entire process from submitting the test license application to the issuance of an MD5 license generally takes 3 to 4 months:
- 1.5 to 2 months: Test license and product testing
- 1 month: Document preparation and application submission
- 1 month: Audit, query responses, and final approval
Proactive management of documentation and prompt responses to queries can help avoid delays.
Government Fees and Costs for Manufacturing License
- Application Fee: Rs 5,000 per application
- Per Product Fee: Rs 500
These fees are payable online via the CDSCO portal. Budget for additional costs such as laboratory testing fees and notified body audit charges, which vary depending on the scope of audit and testing complexity.
Common Challenges and Solutions
Challenge: Delay in product testing due to laboratory backlog.
Solution: Engage early with approved testing labs and submit samples promptly.
Challenge: Incomplete documentation leading to repeated queries.
Solution: Utilize detailed checklists and expert consultation during dossier preparation.
Challenge: Audit non-compliance findings.
Solution: Conduct pre-audit internal reviews using notified body standards.
Challenge: Unfamiliarity with CDSCO portal submissions.
Solution: Allocate trained personnel or hire regulatory consultants experienced with the CDSCO MD Online Portal.
Expert Consultation and Support
With over two decades of experience, we provide end-to-end support including:
- Gap analysis and compliance advisory
- Document preparation and review
- Coordination with notified bodies and testing labs
- Application submission and follow-up
- Training for internal regulatory teams
Our clients appreciate our hands-on approach, which has helped over 500 companies successfully obtain their CDSCO licenses with minimal delays.
Getting Started with Your CDSCO License Application for Cervical Cytology Scraper
- Assess your device classification and verify documentation requirements.
- Initiate the test license application (Form MD13) through the CDSCO MD Online Portal.
- Schedule product testing at a government-approved lab early to avoid bottlenecks.
- Prepare your Device and Plant Master Files referencing our comprehensive guides.
- Engage a notified body for the audit process.
- Submit the MD5 license application (Form MD3) once all preliminary steps are complete.
- Respond promptly to any queries from CDSCO or the audit team.
Starting early and partnering with experienced regulatory consultants can significantly streamline your journey to market. Reach out to us for personalized assistance tailored to your cervical cytology scraper manufacturing or import needs.
By following this expert roadmap, manufacturers and importers can confidently navigate the CDSCO licensing process and bring this vital oncology device to the Indian market efficiently and compliantly.